A Study of XW001 in Healthy Adult Subjects

A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19

NCT05381519 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786

NCT03236233 ·Status: COMPLETED ·Phase: PHASE1

Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)

NCT07272434 ·Status: RECRUITING ·Phase: PHASE3

Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects

NCT04914520 ·Status: COMPLETED ·Phase: PHASE1

A Study of AK0529 in Adults Patients Hospitalized With RSV Infection

NCT06942299 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

NCT05609045 ·Status: WITHDRAWN ·Phase: PHASE1

Safety, Reactogenicity, and Immunogenicity Study of a Lyophilized COVID-19 mRNA Vaccine

NCT05366296 ·Status: WITHDRAWN ·Phase: PHASE1

RSV Challenge in Healthy Adults

NCT00100373 ·Status: COMPLETED ·Phase: NA

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

NCT06645665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine

NCT06754605 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

NCT06083623 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

NCT07205796 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

NCT05303376 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.

NCT00416442 ·Status: COMPLETED ·Phase: PHASE1

A Study of Intranasal ChAdOx1 nCOV-19

NCT04816019 ·Status: COMPLETED ·Phase: PHASE1

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy Adults

NCT06344975 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

NCT06775405 ·Status: RECRUITING ·Phase: PHASE3

Anti-RSV Study in Chinese Patients (ASCENT)

NCT03699202 ·Status: UNKNOWN ·Phase: PHASE2

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

NCT05439824 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults

NCT06287450 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Phase Ia Clinical Study to Evaluate the Safety, Tolerability, PK and Immunogenicity of YBSW015 in Healthy Subjects

NCT05369754 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19

NCT05656443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Real-World Study of JT001 for COVID-19

NCT06142201 ·Status: ACTIVE_NOT_RECRUITING

Safety and Immunogenicity of High-dose IN-B001 in Healthy Subjects

NCT04637919 ·Status: UNKNOWN ·Phase: PHASE1

Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age

NCT03102034 ·Status: COMPLETED ·Phase: PHASE1